Tetrandrine as a Therapeutic Agent for COVID-19: A Review Paper

A review paper collating evidence for tetrandrine's mechanism of action against SARS-CoV-2. The paper argues for repurposing this traditional Chinese medicine compound based on its pharmacodynamics and pharmacokinetics. It was authored by Paula Maria Heister of Addenbrooke's Hospital and published on Papers with Code.

Use Cases

• Literature review on tetrandrine's antiviral mechanisms based on the collated evidence.
• Analysis of drug repurposing strategies for COVID-19 based on the review's arguments.
• Study of calcium channel blockers and two-pore channel antagonists in viral infection based on the proposed mechanism.

Strengths

• Paper is published as Open Access (green license), ensuring free availability.
• The review provides a specific, evidence-based argument for a single therapeutic candidate.

Limitations

• The dataset is a single review paper; it does not contain primary clinical or experimental data.
• Row count and column-level documentation are absent; the content is unstructured text.
• Last update date is unknown; freshness unverified.

Provenance

Source

Paula Maria Heister, Addenbrooke's Hospital

Collection Method

Literature review and evidence collation.